TY - JOUR
T1 - Antibiotic-perturbed microbiota and the role of probiotics
AU - Szajewska, Hania
AU - Scott, Karen P.
AU - de Meij, Tim
AU - Forslund-Startceva, Sofia K.
AU - Knight, Rob
AU - Koren, Omry
AU - Little, Paul
AU - Johnston, Bradley C.
AU - Łukasik, Jan
AU - Suez, Jotham
AU - Tancredi, Daniel J.
AU - Sanders, Mary Ellen
N1 - Publisher Copyright:
© Springer Nature Limited 2024.
PY - 2025/3
Y1 - 2025/3
N2 - The disruptive effect of antibiotics on the composition and function of the human microbiota is well established. However, the hypothesis that probiotics can help restore the antibiotic-disrupted microbiota has been advanced, with little consideration of the strength of evidence supporting it. Some clinical data suggest that probiotics can reduce antibiotic-related side effects, including Clostridioides difficile-associated diarrhoea, but there are no data that causally link these clinical effects to microbiota protection or recovery. Substantial challenges hinder attempts to address this hypothesis, including the absence of consensus on the composition of a ‘normal’ microbiota, non-standardized and evolving microbiome measurement methods, and substantial inter-individual microbiota variation. In this Review, we explore these complexities. First, we review the known benefits and risks of antibiotics, the effect of antibiotics on the human microbiota, the resilience and adaptability of the microbiota, and how microbiota restoration might be defined and measured. Subsequently, we explore the evidence for the efficacy of probiotics in preventing disruption or aiding microbiota recovery post-antibiotic treatment. Finally, we offer insights into the current state of research and suggest directions for future research.
AB - The disruptive effect of antibiotics on the composition and function of the human microbiota is well established. However, the hypothesis that probiotics can help restore the antibiotic-disrupted microbiota has been advanced, with little consideration of the strength of evidence supporting it. Some clinical data suggest that probiotics can reduce antibiotic-related side effects, including Clostridioides difficile-associated diarrhoea, but there are no data that causally link these clinical effects to microbiota protection or recovery. Substantial challenges hinder attempts to address this hypothesis, including the absence of consensus on the composition of a ‘normal’ microbiota, non-standardized and evolving microbiome measurement methods, and substantial inter-individual microbiota variation. In this Review, we explore these complexities. First, we review the known benefits and risks of antibiotics, the effect of antibiotics on the human microbiota, the resilience and adaptability of the microbiota, and how microbiota restoration might be defined and measured. Subsequently, we explore the evidence for the efficacy of probiotics in preventing disruption or aiding microbiota recovery post-antibiotic treatment. Finally, we offer insights into the current state of research and suggest directions for future research.
UR - http://www.scopus.com/inward/record.url?scp=85212190550&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85212190550&partnerID=8YFLogxK
U2 - 10.1038/s41575-024-01023-x
DO - 10.1038/s41575-024-01023-x
M3 - Review article
C2 - 39663462
AN - SCOPUS:85212190550
SN - 1759-5045
VL - 22
SP - 155
EP - 172
JO - Nature Reviews Gastroenterology and Hepatology
JF - Nature Reviews Gastroenterology and Hepatology
IS - 3
M1 - e043054
ER -